SARS-COV-2 Transmission and Adolescent Vaccination | Public Health and CDC/FDA Updates | July 21, 2021
Date of Presentation: July 21, 2021
Type: Past Presentation
Audience: Clinical
Program: Virology
Keywords: #covid #covid updates #public health updates
In this series of presentations, Dr. Thomas Becker, Medical Epidemiologist and ECHO faculty member, reviews the latest articles on SARS-COV-2 transmission. Then, Dr. Eileen M. Dunne, PhD, ECHO faculty member and former Epidemic Intelligence Service Officer for the Centers for Disease Control and Prevention, provides a public health practice update and a number of valuable COVID-19 related resources produced by the CDC and FDA.
Recording:
Presented by:
Dr. Thomas Becker, Dr. Eileen Dunne
Thomas Becker, MD, PhD, has spent his entire career as an epidemiologist focused on Indian health issues. He trained in internal medicine, epidemiology, and anthropology and currently serves as a medical epidemiologist at the Northwest Portland Area Indian Health Board. Although Tom has a variety of research interests, the common theme in his work centers around minority health disparities. He has done extensive community-based projects in partnership with NPAIHB and its 43 member tribes. Tom is passionate about mentoring trainees, primarily MPH students and American Indians who sought research training.
Eileen M. Dunne, PhD, is a former Epidemic Intelligence Service Officer with the Centers for Disease Control and Prevention assigned to the Idaho Department of Health & Welfare. Eileen has a Ph.D. in microbiology from Boston University and spent nine years at the Murdoch Children’s Research Institute in Melbourne, Australia conducting clinical research on pediatric infections and pneumococcal vaccines. Her primary interests include infectious diseases, immunization, and public health.
Resources Provided:
- Joint CDC and FDA Statement on Vaccine Boosters (FDA)
- Johnson & Johnson (Janssen) COVID-19 Vaccine fact sheet updated to include information pertaining to an observed increased risk of Guillain-Barré Syndrome (GBS) following vaccination (FDA)
- COVID-19 Travel Recommendations by Destination (CDC)
- Families with Vaccinated and Unvaccinated Members (CDC)
- Estimated Proportions of SARS-CoV-2 Lineages (CDC)
- Symptoms of Depression, Anxiety, Post-Traumatic Stress Disorder, and Suicidal Ideation Among State, Tribal, Local, and Territorial Public Health Workers During the COVID-19 Pandemic — United States, March–April 2021 (MMWR)
- Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 (MMWR)
- Acceptability of Adolescent COVID-19 Vaccination Among Adolescents and Parents of Adolescents — United States, April 15–23, 2021 (MMWR)
- SARS-CoV-2 B.1.617.2 (Delta) Variant COVID-19 Outbreak Associated with a Gymnastics Facility — Oklahoma, April–May 2021 (MMWR)
- Efficacy of Portable Air Cleaners and Masking for Reducing Indoor Exposure to Simulated Exhaled SARS-CoV-2 Aerosols — United States, 2021 (MMWR)
- Household Transmission of SARS-CoV-2 and Risk Factors for Susceptibility and Infectivity in Wuhan: a retrospective observational study (Lancet)
Date added: September 3, 2021